Interleukin-10 containing normal human serum inhibits granzyme B release but not perforin release from alloreactive and EBV-specific T cell clones

Cellular Immunology

Volumn 251, Issue 1, 2008, Pages 31-36

  Nishimura, Motoko ^a   Sato, Hideya ^a   Okazaki, Hitoshi ^a   Satake, Masahiro ^b   Tadokoro, Kenji ^a  

^a SUWA RED CROSS HOSPITAL   (Japan)

^b Metro Tokyo Red Cross Cord Blood Bank   (Japan)

Author keywords

Alloreactive cytotoxic T cell clone; Anti IL 10 IgG; Epstein Barr virus specific cytotoxic T cell clone; Granzyme B; Interleukin 10; Perforin

Indexed keywords

GRANZYME B; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; PERFORIN;

ALLOIMMUNITY; ARTICLE; CELL CLONE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE;

APOPTOSIS; CELL SURVIVAL; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CLONE CELLS; COCULTURE TECHNIQUES; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GRANZYMES; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-10; PERFORIN; SERUM; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN HERPESVIRUS 4;

EID: 44549083972     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.03.001     Document Type: Article

References (33)

1. Moore K.W., de Waal-Malefyt R., Coffman R.L., and O'Garra A. Interkeukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
2. Grindt M. Humoral immune responses in uremia and the role of IL-10. Blood Purit. 20 (2003) 485-488
3. de Waal-Malefyt R., Haanen J., Spits H., Roncarlo M.G., Te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., and de Vries J.E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II MHC expression. J. Exp. Med. 174 (1991) 915-924
4. Ding L., Linsley P.S., Huang L.-Y., Germain R.N., and Shevach E.M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression. J. Immunol. 151 (1993) 1224-1234
5. Taga K.G., and Tosato G. IL-10 inhibits T cell proliferation and IL-2 production. J. Immunol. 148 (1992) 1143-1148
6. Fiorentino D.F., Bond M.W., and Mossman T.R. Two types of mouse T helper cells IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170 (1989) 2081-2095
7. Fiorentino D.F., Zlotrik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., and O'Garra A. IL-10 acts on antigen presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146 (1991) 3444-3451
8. Bots M., and Medema J.P. Granzymes at a glance. J. Cell. Sci. 24 (2006) 5011-5014
9. Buzze M.S., and Bird P.I. Extracellular granzymes: current perspectives. Boil. Chem. 387 (2006) 827-837
10. Cao X., Cai S.F., Fehniger T.A., Song J., Lollins L.I., Piwnica-Worms D.R., and Ley T.J. Granzyme B and Perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27 (2007) 635-646
11. Maher K.J., Klimas N.G., Hurwitz B., Schiff R., and Fletcher M.A. Quantative fluorescence measures for determination of intracellular perforin content. Clin. Diagn. Lab. Immunol. 9 (2002) 1248-1252
12. Nishimura M., Mitsunaga S., Akaza T., Tadokoro K., and Juji T. Alloreactive feature of HLA-DP-specific cytotoxic T-cell clone. Cell. Immunol. 153 (1994) 262-270
13. Peper R.J., Tina W.Z., and Mickelson M.M. Purification of lymphocytes and platelets by gradient centrifugation. J. Lab. Clin. Med. 72 (1968) 842-848
14. Evans J., Smith M.A., and Steel C.M. Glutaraldehyde and human T cell rosettes. J. Immunol. Methods. 7 (1975) 371-378
15. Roden M.M., Lee K.H., Panelli M.C., and Marincela F.M. A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology. J. Immunol. Methods 226 (1999) 29-41
16. Lichtenfels R., Biddison W.E., Schulz H., Vogt A.B., and Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Methods 172 (1994) 227-239
17. Haque T., Wilkie G.M., Jones M.M., Wilkie G.M., Jones M.M., Higgins C.D., Urquhart G., Wingate P., Burns D., McAulay K., Turner M., Bellamy C., Amlot P.L., Kelly D., MacGilchrist A., Gandhi M.K., Swerdlow A.J., and Crawford D.H. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood 110 (2007) 1123-1131
18. Bosserman L.D., Murray C., Takvorian T., Anderson K.C., Freedman A.S., Fitzsimmons J., Colar F., Nadler L.M., Schlossman S.F., and Ritz J. Mechanisms of graft failure in HLA-matched and HLA-mismatched bone marrow transplant patients. Bone Marrow Tranplant. 4 (1989) 239-245
19. Vooget P.J., Fibbe W.E., Marijt W.A., Goulmy E., Veenhof W.F., Hamilton M., Brand A., Zwann F.E., Willemze R., and von Rood J.J. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 335 (1990) 131-134
20. Vogelsang G.B. Acute and chronic graft-versus-host disease. Curr. Opin. Oncol. 5 (1993) 276-281
21. Rowbottom A.W., Norton J., Riches P.G., Hobbs J.R., Powles R.L., and Sloane J.P. Cytokine gene expression in skin and lymphoid organs in graft versus host disease. J. Clin. Pathol. 46 (1993) 341-345
22. Shivdasani R.A., Haluska F.G., Dock J.S., Kinele E.J., and Anferson K.C. Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N. Engl. J. Med. 328 (1993) 766-770
23. + T-cell clones. Blood 89 (1997) 1440-1445
24. Burns D.M., and Crawford D.H. Epstein-Barr virus-specific cytotoxic T-lymphocytes for adaptive immunotherapy of post-transplant lymphoproliferative disease. Blood Rev. 18 (2004) 193-209
25. Baiocchi O.C., Colleoni G.W., Caballero O.L., Vettore A.L., Bulgarelli A., Dalbone M.A., Granato C.F., Franco M.F., and Pestana J.O. Epstein-Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: a nested case-control study in a renal transplant cohort. Leuk. Lymphoma 46 (2005) 533-539
26. Ozdemir F., Aydin F., Yilmaz M., Kavgaci H., Bektas O., Yavuz M.N., and Yavuz A.A. The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL). J. Exp. Clin. Cancer Res. 23 (2004) 485-488
27. Murray H.W., Moreira A.L., Lu C.M., De Vecchio J.L., Matsuhashi M., Ma X., and Heinzel F.P. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. J. Infect. Dis. 188 (2003) 458-464
28. Brooks D.G., Trifilo M.J., Edelmann K.H., Teyton L., McGavern D.B., and Oldstone M.B. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12 (2006) 1301-1309
29. Leen A.M., Myers G.D., Sili U., Huls M.H., Weiss H., Leung K.S., Garrum G., Gee A.P., Brenner M.K., Heslop H.E., Rooney C.M., and Bollard C.M. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat. Med. 12 (2006) 1160-1166
30. Hammed A., Truong L.D., Price V., Kruhenbuhl O., and Tschopp J. Immunohistochemical localization of granzyme B antigen in cytotoxic cells in human tissues. Am. J. Pathol. 138 (1991) 1069-1075
31. Bird C.H., Sun J., Ung K., Karambalis D., Whisstock J.C., Trapani J.A., and Bird P.I. Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells. Mol. Cell Biol. 25 (2005) 7854-7867
32. Matkar S.S., Wang B., Aquilar-Santelises M., Raja S.M., Uhlin-Hansen L., Podack E., Trapani J.A., and Froelich C.J. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 16 (2002) 417-428
33. San Mateo L.R., Chua M.M., Weiss S.R., and Shen H. Perforin-mediated CTL cytolysis counteracts direct cell-cell spread of Listeria monocytogenes. J. Immunol. 169 (2002) 5202-5208